Wellmune WGP® Helped Stressed Women Stay Healthy, According to Study Published in Journal of the American College of Nutrition

At 12 weeks, there was a 58% reduction in upper respiratory tract infection symptoms

EAGAN, Minn.--(BUSINESS WIRE)--Wellmune WGP^®, a natural immune health ingredient from Biothera, may help stressed women maintain protection against the symptoms of colds, flu and stressors of everyday life, according to results of a new study just published in the Journal of the American College of Nutrition. Click here for a link to the abstract. The study found that moderately to highly stressed women experienced fewer upper respiratory tract infection (URTI) symptoms and higher energy levels while taking Wellmune WGP, a functional ingredient in foods, beverages and supplements in more than 50 countries.

“This is actionable information for women who are seeking more and better ways to keep pace with their daily lives.”

Wellmune WGP, a baker’s yeast beta glucan, is clinically proven to safely prime the immune system to keep the body healthy. Numerous peer-reviewed studies demonstrate that Wellmune WGP mobilizes billions of innate immune cells that are part of the body’s natural defenses without stimulating the immune system.

Study Design and Results
Seventy-seven healthy women (age 38 ± 12 yrs) pre-screened for moderate levels of psychological stress were given either a placebo or 250 mg of Wellmune WGP daily for 12 weeks. Only 10% of the Wellmune group reported upper respiratory tract infection symptoms (sore throat, stuffy or runny nose, and cough) compared with 29% for the control group (p value ≤ 0.05). In other words, the Wellmune group had a 58% reduction in reported URTI symptoms.

The study used the Profile of Mood States (POMS) psychological survey to assess changes in mental/physical energy levels (Vigor) and overall well-being (Global Mood State). Vigor improved 41% in women taking Wellmune WGP compared with 7% in the control group (p value <0.05). Similarly, the Global Mood State of women taking Wellmune improved 29% compared with 16% in the placebo group (p value <0.05).

“This is the first published study exploring the effects of Wellmune WGP on women, a population that arguably faces stressors,” Richard Mueller, chief executive officer, Biothera. “This is actionable information for women who are seeking more and better ways to keep pace with their daily lives.”

“Daily supplementation with Wellmune made a noticeable difference in maintaining health and a positive mental attitude among psychologically stressed women,” said Shawn Talbott, Ph.D., research director at SupplementWatch and lead investigator on the study. “The regimen resulted in reduced incidence of upper respiratory symptoms and improved psychological well being.”

About Wellmune WGP^®
Wellmune WGP is a proprietary baker’s yeast beta 1,3/1,6 glucan that is clinically proven to prime key immune cells that keep the body healthy. This natural food, beverage and supplement ingredient has regulatory approval around the world, including GRAS status in the U.S. and novel foods approval in Europe and China. Wellmune is available in more than 100 products in more than 50 countries around the world. It is also patented, Kosher, Halal, non-allergenic and GMO-free. In addition to receiving an IFT Innovation Award, Wellmune has received a SupplySide West Scientific Excellence Award and a Frost & Sullivan Excellence in Research Award. Wellmune WGP is a product of Biothera, a U.S. biotechnology company dedicated to improving immune health.